Scissor as a platform for the analysis of non-protein subcutaneous formulations

Subcutaneous (SC) therapies have gained more importance over the years as they are more suitable for the administration of chronic therapies than their intravenous (IV) counterparts. Furthermore, with the ageing of the world population, it is particular important to reduce the burden of the health services and since SC formulations do not require supervision by medical professionals to be administered they present an excellent alternative to the current intravenous ones.